Скачать или смотреть Keynote lecture on breast cancer by Prof Jayant Vaidya Oncology Convention, London, 15 Nov 2022

For Oncology Convention 15 November 2022
Improving breast cancer treatment: Long-term results of the TARGIT-A randomised trial (www.targit.org.uk) of risk-adapted single-dose TARGIT-IORT given during lumpectomy for breast cancer vs whole breast radiotherapy given post-operatively by visiting the radiotherapy centre daily for 3 to 6 weeks.
Selected recent scientific papers and talks
1) The BMJ paper is available at https://www.bmj.com/content/370/bmj.m...
The accompanying opinion piece is at https://blogs.bmj.com/bmj/2020/08/19/...
UCL video is at    • TARGIT-IORT during surgery is better for p...  
BMJ academic video is at    • Single dose radiotherapy for women with ea...  

2) Further analysis paper published in the British Journal of Cancer can be accessed at https://www.nature.com/articles/s4141...
and an invited blog post about it is here https://go.nature.com/3ymrplc
and a short video is at    • New insights from the TARGIT A trial 2021  

3) Comparison of 'no-radiotherapy' trials, compressed whole breast radiotherapy trials and other partial breast irradiation randomised trial is published in Nature Reviews Clinical Oncology at https://static-content.springer.com/e... as part of the article https://www.nature.com/articles/s4157...
and in the British Journal of Cancer https://www.nature.com/articles/s4141...

4) Worldwide adoption is described here https://www.frontiersin.org/articles/...

5) How TARGIT-IORT is very different from ELIOT
https://www.thelancet.com/journals/la...

6) How TARGIT-IORT is better for patients than other Partial Breast Irradiation (PBI) approaches
https://www.redjournal.org/article/S0...

7) Red Journal paper https://www.redjournal.org/action/sho...